Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Distribution of and physiologic factors that affect /sup 131/I-antiferritin tumor localization in experimental hepatoma. [Rats]

Journal Article · · Int. J. Radiat. Oncol., Biol. Phys.; (United States)
Polyclonal /sup 131/I rabbit anti-rat ferritin localizes in the H-4-II-E hepatoma model. The effect of tumor size, vascularity, and ferritin content on tumor localization was examined. The extravascular and intravascular quantity and location of /sup 131/I non-specific IgG and /sup 131/I-antiferritin IgG in tumors were determined by gamma counter analysis of tissue samples and autoradiography. Tumor targeting with antiferritin occurred maximally in primary or metastatic lesions less than 1 g in size. Decreased localization occurred with increasing tumor size and no localization took place in tumors > 8 g in size. This finding is independent of administered dose because increasing the amount of injected antiferritin from 2- to 10-fold did not increase the antiferritin/normal IgG targeting ratio in any group of tumors > 4. Tumor vascularity per gram as measured by /sup 51/Cr labeled erythrocytes decreased as tumor size increased. Decreased localization was evident in the necrotic portions of large tumors. These findings have clinical importance since this non-homogeneous distribution of antibody could result in the delivery of low doses of radiation to large necrotic areas of tumors. These results help to demonstrate some of the complex physiologic factors that affect tumor localization and antibody distribution.
Research Organization:
Johns Hopkins Hospital, Baltimore, MD
OSTI ID:
6868500
Journal Information:
Int. J. Radiat. Oncol., Biol. Phys.; (United States), Journal Name: Int. J. Radiat. Oncol., Biol. Phys.; (United States) Vol. 10:7; ISSN IOBPD
Country of Publication:
United States
Language:
English